EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Role of T2 Mapping in Cardiac Amyloidosis

Giulia Grazzini iD, Silvia Pradella iD, Rossella Bani, Chiara Fornaciari, Francesco Cappelli iD, Federico Perfetto iD, Diletta Cozzi iD, Simona Giovannelli, Giacomo Sica iD, Vittorio Miele iD

Diagnostics · 2024-05-18 · 14 (10) · 1048

DOI: 10.3390/diagnostics14101048 ↗

At a glance

Journal article in Diagnostics, published online on 2024-05-18. Written by Giulia Grazzini and 9 co-authors. Institution: Department of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy. Cited 9 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy divided into two types: light-chain (LA) and transthyretin (ATTR) CA. Cardiac magnetic resonance (CMR) has emerged as an important diagnostic tool in CA. While late gadolinium enhancement (LGE), T1 mapping and extracellular volume (ECV) have a consolidate role in the assessment of CA, T2 mapping has been less often evaluated. We aimed to test the value of T2 mapping in the evaluation of CA. This study recruited 70 patients with CA (51 ATTR, 19 AL). All the subjects underwent 1.5 T CMR with T1 and T2 mapping and cine and LGE imaging. Their QALE scores were evaluated. The myocardial T2 values were significantly (p < 0.001) increased in both types of CA compared to the controls. In the AL-CA group, increased T2 values were associated with a higher QALE score. The myocardial native T1 values and ECV were significantly (p < 0.001) higher in the CA patients than in the healthy subjects. Left ventricular (LV) mass, QALE score and ECV were higher in ATTR amyloidosis compared with AL amyloidosis, while the LV ejection fraction was lower (p < 0.001). These results support the concept of the presence of myocardial edema in CA. Therefore, a CMR evaluation including not only myocardial T1 imaging but also myocardial T2 imaging allows for more comprehensive tissue characterization in CA.

Subjects

Author keywords

T2 mappingcardiac amyloidosiscardiac magnetic resonance

Authors and institutions

  • Department of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy.
  • Regional Amyloid Center, Azienda Ospedaliero Universitaria Careggi, Largo Piero Palagi 1, 50134 Florence, Italy.
  • Department of Radiology, Monaldi Hospital, Azienda Ospedaliera dei Colli, 80131 Naples, Italy.

ORCID profiles: Giulia Grazzini, Silvia Pradella, Francesco Cappelli, Federico Perfetto, Diletta Cozzi, Giacomo Sica, Vittorio Miele

Cite

APA

Grazzini, G., Pradella, S., Bani, R., Fornaciari, C., Cappelli, F., Perfetto, F., Cozzi, D., Giovannelli, S., Sica, G., & Miele, V. (2024). The Role of T2 Mapping in Cardiac Amyloidosis. Diagnostics, 14(10), 1048. https://doi.org/10.3390/diagnostics14101048

Vancouver

Grazzini G, Pradella S, Bani R, Fornaciari C, Cappelli F, Perfetto F, et al. The Role of T2 Mapping in Cardiac Amyloidosis. Diagnostics. 2024;14(10):1048. doi:10.3390/diagnostics14101048

BibTeX
@article{Grazzini2024,
  author = {Grazzini, Giulia and Pradella, Silvia and Bani, Rossella and Fornaciari, Chiara and Cappelli, Francesco and Perfetto, Federico and Cozzi, Diletta and Giovannelli, Simona and Sica, Giacomo and Miele, Vittorio},
  title = {The Role of T2 Mapping in Cardiac Amyloidosis},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {10},
  pages = {1048},
  doi = {10.3390/diagnostics14101048}
}
Start for free →